Resistance patterns among nosocomial pathogens: trends over the past few years.
about
Retrospective analysis of antibiotic susceptibility patterns of respiratory isolates of Pseudomonas aeruginosa in a Turkish University HospitalRational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complexInfections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view.Prospective study of the performance of vibrational spectroscopies for rapid identification of bacterial and fungal pathogens recovered from blood culturesGenetic tools for the investigation of Roseobacter clade bacteria.Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophiliaPharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model.Antimicrobial stewardship.EfrAB, an ABC multidrug efflux pump in Enterococcus faecalis.Ramoplanin: a lipoglycodepsipeptide antibiotic.Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeuticColistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci.Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patientsAntibiotic sensitivity profile of bacterial pathogens in postoperative wound infections at a tertiary care hospital in Gujarat, India.Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula.One-step syntheses of nitrofuranyl benzimidazoles that are active against multidrug-resistant bacteria.The rising problem of antimicrobial resistance in the intensive care unit.Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii.Treating serious infections: focus on cefepime.Appropriate and timely empirical antimicrobial treatment of icu infections--a role for carbapenems.A prospective study of the case-notes of MRSA-positive patients: a vehicle of MRSA spreadEffect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key Gram-negative pathogens among patients with hospital-onset urinary tract infectionsLaser-generated shockwaves enhance antibacterial activity against biofilms in vitro.Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.Identification of a small molecule that simultaneously suppresses virulence and antibiotic resistance of Pseudomonas aeruginosa.Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes.Current concepts in antibiotic-resistant gram-negative bacteria.Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer.The current state of multidrug-resistant gram-negative bacilli in North America.Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients.Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.Enhanced antibody responses to a detoxified lipopolysaccharide-group B meningococcal outer membrane protein vaccine are due to synergistic engagement of Toll-like receptorsEvaluation of a scanner-assisted colorimetric MIC method for susceptibility testing of gram-negative fermentative bacteriaTreatment options for multidrug-resistant nonfermenters.Preventing infections in patients undergoing hemodialysis.Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection.Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens.
P2860
Q24806557-05CD70C9-9B14-47EC-AC3B-4929B1686BA8Q27666903-08C77B51-23B5-4775-9E93-9D947D821FCAQ30419577-A005BE2C-78FB-470E-960E-47416292190EQ30879061-51DCED19-1AFF-4401-B475-B89BC2E656A0Q33519700-15332982-C2A9-4312-8961-3A6E35B180C5Q33559105-412BE79A-8A06-401F-88CC-8934C65B0154Q33883685-D51D4048-7BA2-4E15-9068-651D84A7B2CEQ34108660-CD421EBD-BF7A-4ED3-B996-42DF7BA2E66CQ34228050-06350AC6-58D5-4D75-BEBA-E7640157BDEEQ34230365-DA7384AB-522C-4AA3-B49F-72E07698F1CDQ34405651-99BA1CD1-03C3-4163-A891-E71B6177B5F4Q34650340-3EE1DC33-3C65-4AE0-9A22-06DA40134728Q34680516-9EC45DEC-5C6A-4F92-9C09-CD5F78F4EA77Q35006670-492CD299-8EF4-4D8B-8CB9-0C8E5802FB2EQ35023321-D6879C5A-C595-4BF4-8F64-C7C2C471FEB7Q35065863-6F901CCD-1EC1-40AD-AD92-36581AF72F22Q35167721-81C17039-7C02-4F86-B3D6-F9B187B1791DQ35364351-573BFFF5-5852-4A40-8B3C-AEFD7966346DQ35464939-99B94C63-3AE4-4BD0-86FC-AE91A3AAE12EQ35595833-856F9E14-3A3C-4EA3-978E-70221F6CD1E9Q35784520-2D563988-AB1A-447A-808B-8CA76FFCB9BDQ35976856-47B96C56-0120-4449-97FF-14F2755608D9Q36219506-4D018AA3-EEF1-48F8-A20B-791E21A4B58AQ36238225-F95F4D66-DFCA-4536-A08F-87BC3D78C5BFQ36292068-4B272EB6-D2EF-44FB-8636-8EE8BE5C95A6Q36319468-66A88AA4-5110-470D-868C-FD5B2E5F2C2CQ36322117-A51A639E-FFE9-4AB6-9967-5ECD2B3FBBABQ36448826-64892C3D-241A-4C94-A95E-243F62485BF0Q36861645-F359C8E1-2C14-4E91-8F13-125744507C87Q36960068-362E943F-552C-4666-8514-12A0BF01D914Q37055211-8DABA403-B293-4976-909E-D4C478FBC1C0Q37069191-DB9C1671-7129-4253-BF7F-32A73154EF54Q37126210-3CDF38E7-5784-4A6A-9E34-A68BC2848175Q37144834-1B6B96EE-D865-49D4-8C50-3F087BEF10B3Q37260306-0121708E-50D8-4524-BB49-0CA2CA360569Q37318769-AEFB8C60-F738-4F88-907F-6106C6FF71CBQ37700555-22360595-ACA7-4AE6-9D48-77251D521674Q37762541-FD20FC19-9C55-413E-8426-FA1886261BE1Q37843732-E6DE4D11-1F9B-46BE-A817-9DA44F1E8558Q38058355-5652B8AA-90F5-44D1-A98C-05A9FD3FFA84
P2860
Resistance patterns among nosocomial pathogens: trends over the past few years.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Resistance patterns among nosocomial pathogens: trends over the past few years.
@ast
Resistance patterns among nosocomial pathogens: trends over the past few years.
@en
type
label
Resistance patterns among nosocomial pathogens: trends over the past few years.
@ast
Resistance patterns among nosocomial pathogens: trends over the past few years.
@en
prefLabel
Resistance patterns among nosocomial pathogens: trends over the past few years.
@ast
Resistance patterns among nosocomial pathogens: trends over the past few years.
@en
P1433
P1476
Resistance patterns among nosocomial pathogens: trends over the past few years.
@en
P2093
P304
P356
10.1378/CHEST.119.2_SUPPL.397S
P407
P433
P577
2001-02-01T00:00:00Z